University at Buffalo Law School

Vigil Neuroscience Appoints Christopher J. Silber, M.D. as Chief Medical Officer

Retrieved on: 
Monday, August 7, 2023
Tufts University, Laboratory, Lundbeck, Drug development, University, Therapy, Senior, University at Buffalo Law School, Abbott Laboratories, Drug, Biomedical sciences, CNS, AADC, Neuroscience, DSM-IV codes, Jacobs School of Medicine and Biomedical Sciences, Microglia, Hospira, FDA, Regulation of food and dietary supplements by the U.S. Food and Drug Administration, Neurology, Food, Pharmaceutical industry, Psychology, Takeda

as Chief Medical Officer.

Key Points: 
  • as Chief Medical Officer.
  • Dr. Silber brings over 30 years of biopharmaceutical industry experience and a track record of clinical and regulatory success developing novel therapeutics in neuroscience.
  • “We are thrilled to welcome Dr. Silber to Vigil as our new Chief Medical Officer at this pivotal time as we advance VGL101 through Phase 2 clinical development and work towards moving our small molecule program into the clinic later this year,” said Ivana Magovčević-Liebisch, Ph.D., J.D., President and Chief Executive Officer of Vigil.
  • “Vigil’s precision-based development approach targeting microglia represents a new frontier in the treatment of neurodegenerative diseases, which remains an area of high unmet medical need,” said Dr. Silber.

Risk Strategies Expands Allen Blount’s Role to National Cyber and Technology Product Leader

Retrieved on: 
Tuesday, May 23, 2023
Partnership, S&P Global, University, Insurance, Risk Strategies, New York City Law Department, Risk management, University at Buffalo Law School, Blount, SUNY, Global Risks Report, JD, National Cyber Security Authority (Israel), Management, SUNY Polytechnic Institute

BOSTON, May 23, 2023 (GLOBE NEWSWIRE) -- Risk Strategies , a leading national specialty insurance brokerage and risk management firm, today announced that Allen Blount’s role has been expanded to National Cyber and Technology Product Leader.

Key Points: 
  • BOSTON, May 23, 2023 (GLOBE NEWSWIRE) -- Risk Strategies , a leading national specialty insurance brokerage and risk management firm, today announced that Allen Blount’s role has been expanded to National Cyber and Technology Product Leader.
  • Since joining Risk Strategies, Blount has worked in close partnership with Rob Rosenzweig, the Cyber Practice leader, who recently assumed a new leadership role at Risk Strategies.
  • He joined Risk Strategies as the Cyber Team Leader and has been working closely with Rob Rosenzweig to lead the day-to-day operation of the cyber team including CyberResolute, Risk Strategies proprietary market-leading coverage solution for clients under $250M in revenue.
  • “I am excited for the opportunity to continue building on the national cyber and technology strengths at Risk Strategies,” said Blount.

Vivasure Medical Announces Enrollment of First Patients in Pivotal PATCH Study

Retrieved on: 
Tuesday, May 2, 2023
Cardiology, Biotechnology, Health, General Health, Pharmaceutical, Health Technology, Medical Devices, Research, Hospitals, Science, Clinical Trials, Kaleida Health, University, University at Buffalo Law School, Stenosis, Main Line Health, Cardiovascular disease, Trial of the century, CAD, TEVAR, Patient, TAVR, Hospital, EVAR, FDA, Regulation of tobacco by the U.S. Food and Drug Administration, Aortic stenosis, Food, Safety, Pharmaceutical industry, Medical device, Buffalo

Vivasure Medical® , a company pioneering novel fully absorbable technology for percutaneous vessel closure, today announced it has enrolled the first patients in the company’s PerQseal® PATCH Clinical Study, a multi-center, single-arm, pivotal study evaluating the safety and efficacy of the Vivasure PerQseal Closure Device System.

Key Points: 
  • Vivasure Medical® , a company pioneering novel fully absorbable technology for percutaneous vessel closure, today announced it has enrolled the first patients in the company’s PerQseal® PATCH Clinical Study, a multi-center, single-arm, pivotal study evaluating the safety and efficacy of the Vivasure PerQseal Closure Device System.
  • The current approach to large-diameter arterial closure is a surgical repair or the use of suture- or collagen-based closure devices.
  • “I’m honored to participate in this study and look forward to gathering additional clinical evidence supporting this innovation’s potential benefits.”
    Vivasure’s pivotal study will enroll up to 171 patients across the U.S. and up to 90 patients in up to eight European investigational sites.
  • The data will support a pre-market approval submission to the U.S. Food and Drug Administration (FDA).

Wilson Elser Fortifies Medical Malpractice & Health Care Practice with Two Lateral Partners in White Plains and New York Offices

Retrieved on: 
Thursday, September 1, 2022
University, Private practice, The National Law Journal, Brooklyn District Attorney, University at Buffalo Law School, NLJ, Wilson Elser Moskowitz Edelman & Dicker, Obstetrics, New York Law School, Court TV, Brain, Physician, Nursing, Firearm, Auburn University, Hospital, Gynaecology, Medical malpractice, AM, Supreme court, Sheehan, Attention, Specialization, Narcotic, Dentist, Practitioner, Online gambling, Private investigator, Medicine

NEW YORK, Sept. 1, 2022 /PRNewswire/ --National law firm Wilson Elser announced today that two lateral partners have joined the firm's Medical Malpractice & Health Care Practice in the White Plains and New York offices, effective September 1, 2022.

Key Points: 
  • NEW YORK, Sept. 1, 2022 /PRNewswire/ --National law firm Wilson Elser announced today that two lateral partners have joined the firm's Medical Malpractice & Health Care Practice in the White Plains and New York offices, effective September 1, 2022.
  • In returning to the firm, Sheehan will be based in the White Plains office, and Swart will work in the New York City office.
  • "I want to welcome Tim and Joe to the firm and to our practice," said Lori Semlies, co-chair of Wilson Elser's Medical Malpractice & Health Care Practice.
  • "Tim and Joe will strengthen our already deep trial bench and bolster the defense litigation capabilities we offer our clients.

Teleflex Announces First Patient Enrollment in MANTA Ultra Study

Retrieved on: 
Wednesday, June 22, 2022
Cardiology, Security (finance), Length of stay, Franzone, Frequency, Consultant, University, Health, LMA, Associate, GLOBE, Solution, Annual report, Disease, Radiology, Surgeon, Weck, Hemostasis, Haynes, TAVR, Head, University at Buffalo Law School, Meta-analysis, Systematic review, Vascular closure device, Patient, MANTA, BMC, U.S. Securities and Exchange Commission, NYSE, Risk, TAVI, Trial of the century, Mortality, Teleflex, Safety, TFX, Urology, Prostatic urethral lift, U/S, Aortic valve, Anesthesia, Emergency medicine, Medical imaging, MD, QuikClot, Medicine, Pilling

The study will enroll patients undergoing elective TAVR procedures with planned percutaneous femoral arterial access.

Key Points: 
  • The study will enroll patients undergoing elective TAVR procedures with planned percutaneous femoral arterial access.
  • The resourcing of the MANTA Ultra Study by Teleflex reflects our commitment to providing interventional cardiologists and surgeons with category-defining tools that enable difficult procedures and minimize complications in this case, the complications attributable to large bore access that are inherent to TAVI procedures, said Teleflex Medical Director, Chris Buller, MD.
  • Were excited to embark on the Teleflex MANTA Ultra study, said Dr. Wood.
  • With visualization of the access site during MANTA Device deployment, the study intends to demonstrate that ultrasound allows for precise deployment and positive positioning of the MANTA Device anchor within the vessel.

Emma Washington Joins Risk Strategies as National Employee Benefits Practice HR Consulting Leader

Retrieved on: 
Wednesday, June 15, 2022
People, Solution, State university system, Social science, COVID-19, Management consulting, Compliance, Certified Professional in Supply Management, Insurance, Professional in Human Resources, Certification, CP, University at Buffalo Law School, Employee benefits, University, Central Michigan University, Consultant, Life, Workforce, Human resources, Risk management, Accenture, Employment, HR, Human, State University of New York, Human resource management, Organization, GLOBE, SHRM, AON, Management, Tutoring

BOSTON, June 15, 2022 (GLOBE NEWSWIRE) -- Risk Strategies , a leading national specialty insurance brokerage and risk management firm, today announced that Emma Washington has joined the National Employee Benefits Practice as the Human Resources Consulting leader.

Key Points: 
  • BOSTON, June 15, 2022 (GLOBE NEWSWIRE) -- Risk Strategies , a leading national specialty insurance brokerage and risk management firm, today announced that Emma Washington has joined the National Employee Benefits Practice as the Human Resources Consulting leader.
  • Employers have been challenged on many fronts in the past 24 months, including COVID-19 impacts on their workforce, compliance, and a constantly evolving regulatory environment, said John Greenbaum, National Employee Benefits Practice Leader for Risk Strategies.
  • Risk Strategies is a leader in the employee benefits space, said Washington.
  • Risk Strategies is a specialty national insurance brokerage and risk management firm offering comprehensive risk management advice and insurance and reinsurance placement for property & casualty, employee benefits, and private client services risks.

Clinical Studies Support Charlotte's Web CBD Clinic™ Topicals as Safe for Massage and Frequent Use

Retrieved on: 
Wednesday, May 25, 2022
Joint, U.S. Securities and Exchange Commission, Massage, Flavonoid, Biochemistry, Practice, Buffalo, Center, University, Risk, Friction, Safety, Buffalo buffalo Buffalo buffalo buffalo buffalo Buffalo buffalo, Annual report, Tissue, Sleep, Journal, Charlotte's Web (cannabis), News, Menthol, Eucalyptus oil, CBC, COVID-19, Marketing, TSX, Research, University at Buffalo, Heat, CWEB, Bijvoet Centre for Biomolecular Research, Company, Multimedia, Science, CBG, State university system, Cannabidiol, Jacobs School of Medicine and Biomedical Sciences, Genetics, Clove, Charlotte's Web, Faculty, Skin, Phrase, Security (finance), SUNY, MTS, CW, State, Terpene, Muscle, University at Buffalo Law School, Industry, Dog, Absorption, Dietary supplement, Risk management, Cancer, CBD

Studies indicate CBD Clinic hemp topicals for massage do not irritate, or penetrate into the bloodstream, after high-frequency, repeated use such as in massage therapy

Key Points: 
  • Studies indicate CBD Clinic hemp topicals for massage do not irritate, or penetrate into the bloodstream, after high-frequency, repeated use such as in massage therapy
    DENVER, May 25, 2022 /PRNewswire/ - (TSX: CWEB) (OTCQX: CWBHF) Charlotte's Web Holdings, Inc. ("Charlotte's Web," "CW" or the "Company"), the market leader in full-spectrum hemp extract CBD products, today announced results from a series of clinical research studies on frequent use of Charlotte's Web CBD Clinic branded topicals in regular and hot stone massage.
  • "Massage therapists can be confident they're working with some of the safest, highest-quality hemp CBD products when they choose CBD Clinic by Charlotte's Web."
  • CBD Clinic topicals help target varying levels of discomfort through high-quality, naturally derived active ingredients menthol and camphor.
  • Web product categories include full-spectrum hemp CBD oil tinctures (liquid products), CBD gummies (sleep, stress, exercise recovery) , CBD capsules, CBD topical creams and lotions , as well as CBD pet products for dogs .

Lisa M. Goldblatt is recognized by Continental Who's Who

Retrieved on: 
Tuesday, November 2, 2021
University, The arts, Howard County Public School System, Maryland State Bar Association, Catholic University of America, Child, Trustee, View, Law, Associated Builders and Contractors, Divorce, AFD China Intellectual Property Law Office, Leadership, General contractor, Continental, Catholic higher education, Council, Board, Multimedia, Columbus School of Law, University at Buffalo Law School, The Law, Director, Private investigator

ELLICOTT CITY, Md., Nov. 2, 2021 /PRNewswire/ --Proudly serving Howard County, attorney Lisa M. Goldblatt is being recognized by Continental Who's Who as a Top Attorney for her professional excellence in the field of Law, dedication to serving her clients, and her leadership with The Law Office of Lisa M. Goldblatt.

Key Points: 
  • ELLICOTT CITY, Md., Nov. 2, 2021 /PRNewswire/ --Proudly serving Howard County, attorney Lisa M. Goldblatt is being recognized by Continental Who's Who as a Top Attorney for her professional excellence in the field of Law, dedication to serving her clients, and her leadership with The Law Office of Lisa M. Goldblatt.
  • Founding partner, Lisa M. Goldblatt brings decades of professional excellence and invaluable insight to lead clients through their family law cases to obtain positive results.
  • Attorney Lisa Goldblatt has led an impressive career for nearly 20 years.
  • As the sole counselor at the Law Office of Lisa M. Goldblatt, Ms. Goldblatt has maintained a laudable reputation within the legal community and throughout Howard and Baltimore County.

Xin Tian, Esq., Recognized for Excellence in Patent Law and Scientific Research

Retrieved on: 
Wednesday, October 13, 2021
View, Technology, Religion, University at Buffalo Law School, Librarian, Bachelor of Science in Human Biology, Who, Institute of Electrical and Electronics Engineers, China Pharmaceutical University, Politics, Education, Multimedia, Medicine, Law school, Biology, Edition (book), Biotechnology, Information, University, Marquess, Electricity, Institute, Master of Science in Health Informatics, Patent, Data mining, Thomson Reuters, Prefabrication, Pharmaceutical industry

Factors such as position, noteworthy accomplishments, visibility, and prominence in a field are all taken into account during the selection process.

Key Points: 
  • Factors such as position, noteworthy accomplishments, visibility, and prominence in a field are all taken into account during the selection process.
  • Born in China, Mr. Tian's interest in science drew him to China Pharmaceutical University in the city of Nanjing.
  • While completing a Bachelor of Science in biotechnology, he discovered that the United States and China had very different philosophies concerning the law and bared extremely different bodies of regulations regarding scientific research.
  • Mr. Tian is proud to help regulatory bodies adapt to the inevitable emergence of new areas of scientific research, especially in relation to health care.